Pentasa
Brand Name: Pentasa
Generic Name: Mesalazine
Active
Registration Number
DR-XY26649
Dosage Form
Prolonged-Release Tablet
Issuance Date
February 2, 2023
Expiry Date
March 6, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength500 mg
PackagingAlu/Alu Blister Pack x 10's (Box of 100's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
BOWEL ANTI-INFLAMMATORY
A
Application
Automatic Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
MesalazineActive
Monograph: Mesalazine